News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SMITH TODD N
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/22/2020 |
4
| SMITH TODD N (Director, Pres & CEO) has filed a Form 4 on Assertio Holdings, Inc.|
Txns:
| Granted 644,925 shares
@ $0
Granted 603,750 options to buy
@ $0.6, valued at
$362.3k
Granted 450,000 options to buy
@ $0.948, valued at
$426.6k
|
|
| 05/22/2020 |
3
| SMITH TODD N (Director, Pres & CEO) has filed a Form 3 on Assertio Holdings, Inc. |
| 05/21/2020 |
4
| SMITH TODD N (President and CEO) has filed a Form 4 on Zyla Life Sciences|
Txns:
| Disposed/sold 365,500 shares
@ $0
Disposed/sold 241,500 options to buy
@ $1.5, valued at
$362.3k
Disposed/sold 180,000 options to buy
@ $2.37, valued at
$426.6k
|
|
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/04/2015 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 01/06/2015 |
4
| SMITH TODD N (SVP & CCO) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Granted 5,500 options to buy
@ $45.6, valued at
$250.8k
Granted 1,400 restricted stock units
@ $0 |
|
| 10/07/2014 |
4
| SMITH TODD N (SVP & CCO) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Granted 150,000 options to buy
@ $38.41, valued at
$5.8M
|
|
| 09/22/2014 |
4
| SMITH TODD N (EVP & Chief Commercial Officer) has filed a Form 4 on Horizon Pharma plc|
Txns:
| Granted 54,138 shares
@ $0
Granted 18,955 options to buy
@ $20.78, valued at
$393.9k
Granted 21,880 options to buy
@ $4.96, valued at
$108.5k
Granted 6,699 restricted stock units
@ $0
Granted 61,000 options to buy
@ $2.4, valued at
$146.4k
Granted 41,250 restricted stock units
@ $0
Granted 70,000 options to buy
@ $7.61, valued at
$532.7k
Granted 62,000 restricted stock units
@ $0 |
|
| 09/22/2014 |
4
| SMITH TODD N (EVP, Chief Commercial Officer) has filed a Form 4 on Horizon Pharma plc|
Txns:
| Disposed/sold 54,138 shares
@ $0
Disposed/sold 18,955 options to buy
@ $20.78, valued at
$393.9k
Disposed/sold 21,880 options to buy
@ $4.96, valued at
$108.5k
Disposed/sold 6,699 restricted stock units
@ $0
Disposed/sold 61,000 options to buy
@ $2.4, valued at
$146.4k
Disposed/sold 41,250 restricted stock units
@ $0
Disposed/sold 70,000 options to buy
@ $7.61, valued at
$532.7k
Disposed/sold 62,000 restricted stock units
@ $0 |
|
| 05/21/2014 |
4
| SMITH TODD N (EVP & Chief Commercial Officer) has filed a Form 4 on HORIZON PHARMA, INC.|
Txns:
| Sold 10,159 shares
@ $12.94, valued at
$131.5k
|
|
| 01/10/2014 |
4
| SMITH TODD N (EVP & Chief Commercial Officer) has filed a Form 4 on HORIZON PHARMA, INC.|
Txns:
| Granted 70,000 options to buy
@ $7.61, valued at
$532.7k
Granted 62,000 restricted stock units
@ $0 |
|
| 12/09/2013 |
4
| SMITH TODD N (EVP & Chief Commercial Officer) has filed a Form 4 on HORIZON PHARMA, INC.|
Txns:
| Granted 18,037 shares
@ $0
Sold 1,322 shares
@ $6.79, valued at
$9k
Sold 10,000 shares
@ $6.93, valued at
$69.3k
Exercised 3,350 restricted stock units
@ $0 |
|
| 01/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/09/2011 |
4
| SMITH TODD N (SVP, Marketing & Alliance Mgmt) has filed a Form 4 on HORIZON PHARMA, INC.|
Txns:
| Granted 21,880 options to buy
@ $4.96, valued at
$108.5k
Granted 13,397 restricted stock units
@ $0 |
|
| 07/28/2011 |
3
| SMITH TODD N (SVP, Marketing & Alliance Mgmt) has filed a Form 3 on HORIZON PHARMA, INC. |
|
|